Works by Maderer, Annett

Results: 17
    1

    Collagen turnover biomarkers to predict outcome of patients with biliary cancer.

    Published in:
    BMC Gastroenterology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12876-025-03645-0
    By:
    • Kaps, Leonard;
    • Genc, Muhammed A.;
    • Moehler, Markus;
    • Grabbe, Stephan;
    • Schattenberg, Jörn M.;
    • Schuppan, Detlef;
    • Pedersen, Rasmus Sund;
    • Karsdal, Morten A.;
    • Mildenberger, Philipp;
    • Maderer, Annett;
    • Willumsen, Nicholas
    Publication type:
    Article
    2

    Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071).

    Published in:
    2018
    By:
    • Moehler, Markus;
    • Schad, Arno;
    • Maderer, Annett;
    • Atasoy, Ajlan;
    • Mauer, Murielle E.;
    • Caballero, Carmela;
    • Thomaidis, Thomas;
    • John, Jestinah M. Mahachie;
    • Lang, Istvan;
    • Van Cutsem, Eric;
    • Freire, João;
    • Lutz, Manfred P.;
    • Roth, Arnaud;
    • the EORTC Gastrointestinal Tract Cancer Group;
    • EORTC Gastrointestinal Tract Cancer Group
    Publication type:
    journal article
    3
    4

    Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 3, p. 515, doi. 10.1007/s00432-014-1829-6
    By:
    • Moehler, Markus;
    • Thomaidis, Thomas;
    • Zeifri, Chourouk;
    • Barhoom, Tareq;
    • Marquardt, Jens;
    • Ploch, Philippe;
    • Schattenberg, Joern;
    • Maderer, Annett;
    • Schimanski, Carl;
    • Weinmann, Arndt;
    • Woerns, Marcus;
    • Kranich, Anne;
    • Warnecke, Jens;
    • Galle, Peter
    Publication type:
    Article
    5
    6
    7
    8

    Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.963753
    By:
    • Ledenko, Matthew;
    • Antwi, Samuel O.;
    • Shiho Arima;
    • Driscoll, Julia;
    • Junji Furuse;
    • Klümpen, Heinz-Josef;
    • Larsen, Finn Ole;
    • Lau, David K.;
    • Maderer, Annett;
    • Markussen, Alice;
    • Moehler, Markus;
    • Nooijen, Lynn E.;
    • Shaib, Walid L.;
    • Tebbutt, Niall C.;
    • André, Thierry;
    • Makoto Ueno;
    • Woodford, Rachel;
    • Changhoon Yoo;
    • Zalupski, Mark M.;
    • Patel, Tushar
    Publication type:
    Article
    9

    Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2).

    Published in:
    Strahlentherapie und Onkologie, 2020, v. 196, n. 9, p. 795, doi. 10.1007/s00066-020-01646-4
    By:
    • Rades, Dirk;
    • Bartscht, Tobias;
    • Hunold, Peter;
    • Schmidberger, Heinz;
    • König, Laila;
    • Debus, Jürgen;
    • Belka, Claus;
    • Homann, Nils;
    • Spillner, Patrick;
    • Petersen, Cordula;
    • Kuhnt, Thomas;
    • Fietkau, Rainer;
    • Ridwelski, Karsten;
    • Karcher-Kilian, Kerstin;
    • Kranich, Anne;
    • Männikkö, Sofia;
    • Schild, Steven E.;
    • Maderer, Annett;
    • Moehler, Markus
    Publication type:
    Article
    10
    11

    Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/s13046-014-0083-8
    By:
    • Thomaidis, Thomas;
    • Maderer, Annett;
    • Formentini, Andrea;
    • Bauer, Susanne;
    • Trautmann, Mario;
    • Schwarz, Michael;
    • Neumann, Wiebke;
    • Kittner, Jens Martin;
    • Schad, Arno;
    • Link, Karl-Heinrich;
    • Rey, Johannes Wilhelm;
    • Weinmann, Arndt;
    • Hoffman, Arthur;
    • Galle, Peter Robert;
    • Kornmann, Marko;
    • Moehler, Markus
    Publication type:
    Article
    12

    VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-476
    By:
    • Thomaidis, Thomas;
    • Maderer, Annett;
    • Al-Batran, Salah-Eddin;
    • Kany, Janis;
    • Pauligk, Claudia;
    • Steinmetz, Kristina;
    • Schad, Arno;
    • Hofheinz, Ralf;
    • Schmalenberg, Harald;
    • Homann, Nils;
    • Galle, Peter Robert;
    • Moehler, Markus
    Publication type:
    Article
    13

    VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

    Published in:
    2014
    By:
    • Thomaidis, Thomas;
    • Maderer, Annett;
    • Al-Batran, Salah-Eddin;
    • Kany, Janis;
    • Pauligk, Claudia;
    • Steinmetz, Kristina;
    • Schad, Arno;
    • Hofheinz, Ralf;
    • Schmalenberg, Harald;
    • Homann, Nils;
    • Galle, Peter Robert;
    • Moehler, Markus
    Publication type:
    journal article
    14

    Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3).

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 8, p. 1341, doi. 10.1002/ijc.33881
    By:
    • Moehler, Markus;
    • Folprecht, Gunnar;
    • Heinemann, Volker;
    • Holch, Julian Walter;
    • Maderer, Annett;
    • Kasper, Stefan;
    • Hegewisch‐Becker, Susanna;
    • Schröder, Jan;
    • Overkamp, Friedrich;
    • Kullmann, Frank;
    • Bechstein, Wolf Otto;
    • Vöhringer, Matthias;
    • Öllinger, Robert;
    • Lordick, Florian;
    • Geißler, Michael;
    • Schulz‐Abelius, Armin;
    • Linz, Bernhard;
    • Bernhard, Helga;
    • Paul, Andreas;
    • Schmidtmann, Irene
    Publication type:
    Article
    15
    16

    Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.

    Published in:
    2016
    By:
    • Moehler, Markus;
    • Gepfner-Tuma, Irina;
    • Maderer, Annett;
    • Thuss-Patience, Peter C.;
    • Ruessel, Joern;
    • Hegewisch-Becker, Susanna;
    • Wilke, Hansjochen;
    • Al-Batran, Salah-Eddin;
    • Rafiyan, Mohammad-Reza;
    • Weiβinger, Florian;
    • Schmoll, Hans-Joachim;
    • Kullmann, Frank;
    • von Weikersthal, Ludwig Fischer;
    • Siveke, Jens T.;
    • Weusmann, Jens;
    • Kanzler, Stephan;
    • Schimanski, Carl Christoph;
    • Otte, Melanie;
    • Schollenberger, Lukas;
    • Koenig, Jochem
    Publication type:
    journal article
    17